Clinical research, funded by the US National Eye Institute (NEI), and led by a broad consortium of ophthalmology experts at 66 clinical / academic sites… Read More »NEI sponsored “Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2)” demonstrates equivalence between Avastin and Eylea in CRVO
An opinion paper authored by experts at the Medical Products Agency Uppsala, Sweden, and the European Medicines Agency, London, UK, has highlighted the need for… Read More »Regulators highlight that the development of new and clinically relevant biomarkers are key steps in accelerating the evaluation of novel ocular therapies.
by Dr. Gearóid Tuohy Dear EURETINA Members, A very warm welcome to the May 25th, 2017 edition of EURETINA’s web-based digital magazine, “EURETINA… Read More »May 25th, 2017: “EURETINA-Brief”© Issue No. 154
RegenxBio Inc. (NASDAQ:RGNX), Rockville, Maryland, USA, has announced the successful raising of $75.9 million through the sale of 3.7 million shares at $20.50/share in a… Read More »RegenxBio Inc. (NASDAQ:RGNX) raises additional investment funds as long term product for novel wet AMD study enters phase I clinical testing.
Researchers from the Diabetes Control and Complications Trial (DCCT), and the Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group, have published comprehensive findings indicating… Read More »New screening algorithm for diabetic retinopathy progression may save $1 billion over 20 years according to research consortium.
Scientists based at the Department of Ophthalmology, Columbia University, New York, have shown that manipulating a metabolic pathway in photoreceptor cells may provide benefit in… Read More »Pre-clinical research shows re-programming of sugar metabolism may benefit electrophysiology and retinal anatomy in retinitis pigmentosa (RP) models.
by Dr. Gearóid Tuohy Dear EURETINA Members, A very warm welcome to the May 1st, 2017 edition of EURETINA’s web-based digital magazine, “EURETINA… Read More »May 1st, 2017: “EURETINA-Brief”© Issue No. 153
A UK newspaper, The Guardian, has reported that EU officials will shortly be scheduling the transfer of EU agencies out of the UK as part… Read More »EMA exit from London may be sooner than originally anticipated creating additional uncertainty for drug approvals
Researchers from the Japanese RIKEN Centre have reportedly delivered induced pluripotent stem (iPS) cells from an anonymous donor to a 60 year old male patient.… Read More »Induced pluripotent stem (iPS) cells from a donor cell bank may open a new paradigm shift in stem cell treatment.
Scientists based at the University of California, Berkeley, have published results of a study showing how a small molecule “photo-switch” –a molecule that changes conformation… Read More »Long lasting retinal photo-switch restores visual function after a single intra-ocular injection.